Secular trends in kidney disease: Is the decreased incidence of renal replacement therapy due to a decrease in chronic kidney disease incidence?

Clinical Nephrology

Volumn 70, Issue 3, 2008, Pages 187-193

  Thorp, M L ^a   Weinstein, J R ^b   Johnson, E S ^c   Yang, X ^c   Smith, David H ^c  

^a KAISER PERMANENTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

Chronic kidney disease; Diabetes; Renal replacement therapy; Secular trends; Transplantation

Indexed keywords

CREATININE;

ADULT; AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE ORGANIZATION; HEALTH MAINTENANCE ORGANIZATION; HEMODIALYSIS; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY TRANSPLANTATION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY; SEX DIFFERENCE; UNITED STATES;

EID: 52149090551     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp70187     Document Type: Article

References (13)

1. CDC. State-specific trends in chronic kidney failure - United States, 1990-2001. MMWR Morb Mortal Wkly Rep. 2004; 53: 918-920.
2. CDC. Incidence of end-stage renal disease among persons with diabetes - United States, 1990-2002. MMWR Morb Mortal Wkly Rep. 2005; 54: 1097-1100.
3. Clayton D, Hills M. Poisson and logistic regression. Statistical models in epidemiology. New York: Oxford University Press; 1993. p. 227-236.
4. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van LF, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298: 2038-2047.
5. Greenlick M, Freeborn D, Pope C. Health care research in an HMO: Two decades of discovery. Baltimore: Johns Hopkins University Press; 1998.
6. Johnson ES, Koepsell TD, Reiber G, Stergachis A, Platt R. Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol. 2002; 55: 253-259.
7. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 1998; 32: 992-999.
8. K/DOQI. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1-266.
9. Schaubel DE, Morrison HI, Desmeules M, Parsons DA, Fenton SSA. End-stage renal disease in Canada: prevalence projections to 2005. Can Med Assoc J. 1999; 160: 1557-1563.
10. Stengel B, Billon S, van Dijk PCW, Jager KJ, Dekker FW, Simpson K, Briggs JD. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant. 2003; 18: 1824-1833.
11. US Renal Data System. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
12. van Dijk PCW, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int. 2005; 67: 1489-1499.
13. Wilson PWF, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham Experience. Arch Int Med. 2002; 162: 1867-1872.